| Therapeutic vaccines for tuberculosis: an overview R Bouzeyen, B Javid Frontiers in Immunology 13, 878471, 2022 | 60 | 2022 |
| VapBC22 toxin-antitoxin system from Mycobacterium tuberculosis is required for pathogenesis and modulation of host immune response S Agarwal, A Sharma, R Bouzeyen, A Deep, H Sharma, ... Science advances 6 (23), eaba6944, 2020 | 40 | 2020 |
| FOXO3 transcription factor regulates IL-10 expression in mycobacteria-infected macrophages, tuning their polarization and the subsequent adaptive immune response R Bouzeyen, M Haoues, MR Barbouche, R Singh, M Essafi Frontiers in Immunology 10, 2922, 2019 | 35 | 2019 |
| NU-6027 inhibits growth of Mycobacterium tuberculosis by targeting protein kinase D and protein kinase G S Kidwai, R Bouzeyen, S Chakraborti, N Khare, S Das, T Priya Gosain, ... Antimicrobial agents and chemotherapy 63 (9), 10.1128/aac. 00996-19, 2019 | 33 | 2019 |
| An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis S Krishnananthasivam, H Li, R Bouzeyen, B Shunmuganathan, ... npj Vaccines 8 (1), 127, 2023 | 12 | 2023 |
| Restoration of cytosolic calcium inhibits Mycobacterium tuberculosis intracellular growth: theoretical evidence and experimental observation A Gupta, PN Das, R Bouzeyen, SP Karmakar, R Singh, N Bairagi, ... Journal of Theoretical Biology 472, 110-123, 2019 | 7 | 2019 |
| 3D QSAR-based design and liquid phase combinatorial synthesis of 1, 2-disubstituted benzimidazole-5-carboxylic acid and 3-substituted-5 H-benzimidazo [1, 2-d][1, 4 … ND Sitwala, VK Vyas, P Gedia, K Patel, R Bouzeyen, S Kidwai, R Singh, ... MedChemComm 10 (5), 817-827, 2019 | 7 | 2019 |
| Disulfiram inhibits M. tuberculosis growth by altering methionine pool, redox status and host-immune response D Chaudhary, M Marzuki, A Lee, R Bouzeyen, A Singh, TP Gosain, ... BioRxiv, 2020.09. 01.277368, 2020 | 4 | 2020 |
| Polyphosphate kinase-1 regulates bacterial and host metabolic pathways involved in pathogenesis of Mycobacterium tuberculosis S Chugh, P Tiwari, C Suri, SK Gupta, P Singh, R Bouzeyen, S Kidwai, ... Proceedings of the National Academy of Sciences 121 (2), e2309664121, 2024 | 3 | 2024 |
| Co-Administration of Anticancer Candidate MK-2206 Enhances the Efficacy of BCG Vaccine Against Mycobacterium tuberculosis in Mice and Guinea Pigs R Bouzeyen, S Chugh, TP Gosain, MR Barbouche, M Haoues, KVS Rao, ... Frontiers in Immunology 12, 645962, 2021 | 3 | 2021 |
| Author Correction: An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis S Krishnananthasivam, H Li, R Bouzeyen, B Shunmuganathan, ... npj Vaccines 8, 2023 | | 2023 |
| Co-Administration of Anticancer Candidate MK-2206 Enhances the Efficacy of BCG Vaccine Against R Bouzeyen, S Chugh, TP Gosain, MR Barbouche, M Haoues, KVS Rao, ... Repurposed Drugs as Immune-Modulators to Combat Infectious Diseases, 2022 | | 2022 |
